Longevity supplements target biological aging pathways: mitochondrial function, senolytic clearance, AMPK activation, and chronic inflammation. The field is young and evidence is evolving rapidly.
- Nicotinamide riboside (NR) or NMN (250β500 mg/day): Well-documented NAD+ elevation in humans. Functional outcome data is still emerging.
- Fisetin (100 mg/day pulsed 2 days/month): Senolytic β clears senescent cells in animal models. Human trials are ongoing.
- Spermidine (1β5 mg/day): Induces autophagy. Associated with lower cardiovascular mortality in observational studies.
- Quercetin (500β1000 mg/day): Senolytic and antioxidant. Often paired with fisetin.
- Omega-3 (1β2 g EPA+DHA/day): Reduces cardiovascular mortality in populations with low baseline omega-3 intake.
- Vitamin D3 + K2 (2000β4000 IU D3, 100 mcg MK-7): Cardiovascular and bone benefits.
- Rapamycin or metformin marketed as supplements β these are prescription drugs
- Unvalidated senolytic cocktails with unclear dosing
- Products promising "lifespan extension" based on animal data alone
- Underdosed spermidine (< 1 mg/day has no meaningful effect)
Scientific literature depth behind each ingredient, dose matching human trial protocols, third-party testing, and honest framing of what longevity supplements can and cannot do today.